

Description of the drug Venarus
Venarus coated tablets:
1 tab. Venarus contains diosmin 450 mg, hesperidin 50 mg;
excipients: gelatin, Magnesium stearate, microcrystalline cellulose, sodium starch glycolate, talc;
shell composition: polyethylene glycol 6000, magnesium stearate, hydroxypropyl methylcellulose, sodium lauryl sulfate, titanium dioxide, ferric oxide red, ferric oxide yellow;
Pack of 20, 30, 45 or 60 pcs.
Venarus has an angioprotective, venotonic effect.
Venous insufficiency of the lower limbs (functional, organic): feeling of heaviness in the legs, pain, cramps, trophic disorders; acute hemorrhoidal attack.
Hypersensitivity.
In pregnancy, it is possible (in the experiments, no teratogenic effect was detected; to date, no adverse effects have been reported with the use of the drug Venarus in pregnant women).
Category of action on the fetus by the FDA - not determined.
During lactation is not recommended (there is no data on the penetration of the drug Venarus into breast milk).
Dyspeptic phenomena, vegetative lability.
Venarus taken inside. When venous insufficiency: 1-2 pills / day (at noon and in the evening during meals). In acute hemorrhoids: 6 pills / day for the first 4 days, then 4 tables / day for 3 days.
In the dark place at a temperature of no higher than 25 ° C.